Mitochondrial DNA‐cGAS‐STING induces macrophage pyroptosis via phospho‐IRF3‐mediated NLRP3 expression in ionising radiation‐induced atherosclerosis progression
BACKGROUND AND PURPOSE: Ionising radiation (IR) is a major cancer-treatment modality, yet the mechanisms driving IR-triggered cardiovascular injury are poorly defined. This work aimed to uncover how IR accelerates atherosclerosis (AS) and the underlying molecular mechanisms. EXPERIMENTAL APPROACH: We applied 9.4 T magnetic resonance imaging to evaluate atherosclerotic lesions. Single-cell RNA sequencing was performed on carotid arteries. Apolipoprotein E (ApoE) knockout mice with caspase-1 deletion and macrophage-specific cGAS knockdown were used for in vivo validation. JASPAR prediction and dual-luciferase reporter assays were implemented to verify transcriptional regulation of NLRP3. KEY RESULTS: IR substantially aggravated atherosclerotic progression, accompanied by elevated pyroptosis-related gene expression in macrophages within atherosclerotic plaques. Mechanistically, IR promoted cytoplasmic mtDNA release to activate the cGAS/STING/TBK1 axis and cause p-IRF3 nuclear translocation. Phosphorylated IRF3 bound to the NLRP3 promoter and enhanced its transcription. Genetic ablation of caspase-1 or macrophage-specific cGAS knockdown alleviated IR-driven AS progression. CONCLUSIONS AND IMPLICATIONS: Macrophage pyroptosis drives IR-accelerated AS progression through the mtDNA/cGAS/STING/p-IRF3 axis-dependent transcriptional up-regulation of NLRP3. Targeting the cGAS-STING pathway may provide a therapeutic strategy for IR-associated atherosclerotic plaque progression.
Authors
- Yamin Jie (ORCID: https://orcid.org/0009-0001-3512-4172)
- Shan Jiang (ORCID: https://orcid.org/0000-0003-1015-1278)
- Sainan Pang (ORCID: https://orcid.org/0009-0008-3657-7414)
- Yuwu Chen (ORCID: https://orcid.org/0009-0001-2156-6965)
- Tian Luan (ORCID: https://orcid.org/0000-0003-4284-7990)
- E Mingyan (ORCID: https://orcid.org/0000-0001-5127-6400)
- Xing Luo (ORCID: https://orcid.org/0000-0003-1096-6629)
- Quan Lin (ORCID: https://orcid.org/0000-0002-1481-2793)
- D C Yu (ORCID: https://orcid.org/0000-0002-2171-9845)
- Anxin Gu (ORCID: https://orcid.org/0000-0002-6210-5233)
- Xin Guan (ORCID: https://orcid.org/0009-0005-6426-9556)
- Jiayin Liu (ORCID: https://orcid.org/0009-0009-6707-522X)
- Zixuan Liu (ORCID: https://orcid.org/0009-0006-2662-2053)
- Manru Shi (ORCID: https://orcid.org/0009-0001-4934-087X)
- Jiaao Liu (ORCID: https://orcid.org/0009-0005-8301-3898)
- Muping Liu (ORCID: https://orcid.org/0009-0009-5513-4413)
- Yang Cao (ORCID: https://orcid.org/0009-0008-8178-3380)
- Xinxin Zhu (ORCID: https://orcid.org/0009-0006-4018-6526)
- Shaohua Ding (ORCID: https://orcid.org/0009-0005-8496-2403)
- Dandan Sun (ORCID: https://orcid.org/0009-0004-0388-6924)
Institutions
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Fourth Affiliated Hospital of Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1111/bph.70731
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province